| Doctors will be able to prescribe the medication, called lecanemab, which removes a sticky protein from the brain that is thought to play a key role in the memory-robbing illness afflicting 6 million Americans. Many neurologists and advocates welcomed the Food and Drug Administration action, but other experts doubt that the drug's benefits will be robust enough to outweigh concerns about potentially serious complications. | 
No comments:
Post a Comment